HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naokazu Gion Selected Research

Agammaglobulinaemia Tyrosine Kinase

5/2019Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naokazu Gion Research Topics

Disease

1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2019
1Neoplasms (Cancer)
05/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2019

Drug/Important Bio-Agent (IBA)

1tirabrutinibIBA
05/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
05/2019
1Biomarkers (Surrogate Marker)IBA
05/2019